News & Press
European Pharmaceutical Manufacturer – September/October, 2020 / Page 36
Personalised medicine has been one of the main trends in the pharmaceutical sector over the past few years. While the increased demand for tailored therapies is a great opportunity, it also poses new challenges.
Unlike the classic top-down approach, where drugs are produced in large volumes, personalised medicine requires smaller batches and different formats. For manufacturers, this creates the need to be more flexible with their production and the ability to move efficiently between different projects and packaging.
THE LIMITS OF TRADITIONAL FILLING TECHNOLOGY
That was exactly the challenge CordenPharma – a full-service CDMO for the integrated supply of APIs, drug products and packaging services – was facing when it decided to expand its portfolio of primary packaging for anaesthetics.
CordenPharma’s growth and evolution from filling generics in bulk containers to value-added treatments using fill & finish multi-format lines for ready-to-fill vials and syringes, increased the need for flexibility and a faster ram-pup. With traditional technology, however, this expansion would have been problematic.